Recent Quotes (30 days)

You have no recent quotes
chg | %

Immunodiagnostic Systems Hldgs PLC  

(Public, LON:IDH)   Watch this stock  
Find more results forIDH
325.00
-5.00 (-1.52%)
Oct 20 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 325.00 - 325.00
52 week 163.25 - 325.00
Open 325.00
Vol / Avg. 43.00/63.00
Mkt cap 98.57M*
P/E 31.77
Div/yield 4.00*
EPS 0.10*
Shares 29.41M
Beta     -
Inst. own     -
*GBP
Jul 27, 2017
Immunodiagnostic Systems Holdings PLC Annual Shareholders Meeting
  

Key stats and ratios

Q1 (Mar '17) 2017
Net profit margin 7.42% 7.52%
Operating margin 3.73% 4.12%
EBITD margin - 19.49%
Return on average assets 4.48% 4.59%
Return on average equity 5.43% 5.56%
Employees 275 -
CDP Score - -

Address

10 Didcot Way
BOLDON, NE35 9PD
United Kingdom - Map
+44-191-5190660 (Phone)
+44-191-5190760 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Immunodiagnostic Systems Holdings PLC is a specialist in vitro diagnostic solution provider to the clinical laboratory market. The Company develops, manufactures and markets immunoassays and automated immunoanalyser technologies. It operates through three business segments: Automated IVD, Manual IVD, and Licensing & Technology. The automated IVD business consists of 25-OH Vitamin D, specialties and instrument sales. The automated IVD business also consists of the sale or placement of its IDS-iSYS instrument, in addition to selling automated assays and consumables for use in these instruments. The Manual IVD business sells manual assays, radio immunoassays (RIA) and ELISA kits (EIA) to labs. Its assay development is focused in the clinical areas, such as calcium metabolism, bone metabolism, chronic kidney disease, hypertension, fertility and growth. Its subsidiaries include Immunodiagnostic Systems Limited, Immunodiagnostic Systems Nordic A/S and Immunodiagnostic Systems France SAS.

Officers and directors

Regis Duval Chief Executive Officer
Age: 45
Paul James Martin Group Finance Director, Director
Age: 38
Andrew J. Davison Company Secretary
Burkhard Wittek Ph.D. Non-Executive Chairman of the Board
Till Bengt Campe Non-Executive Director
Age: 24
Klaus Peter Kaspar Non-Executive Director
Age: 63
Peter John Williamson Non-Executive Director
Age: 50
Roland Sackers Senior Non-Executive Independent Director